Complete Motor Sparing Protocol Versus Fascia Iliaca Suprainguinal Technique for Total Hip Arthroplasty, a Prospective Randomized Clinical Trial.
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Measurement of opioid use
研究概览
简要总结
Complete motorsparing protocol (CMP) has been developed to try to minimize the motor nerve block that is created when using Facia iliaca nerve block. The blocks performed in the (CMP) are the cluneal nerve block, Pericapsular nerve group block and lateral femoral cutaneous block. On the clinical trial, the investigators will randomize the participants that meet criteria to CMP or Fascia iliaca Block and compare the amount of opioid needed post op during 24 hours and their pain scores.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Patients ≥ 18 years old
- •Patients undergoing total hip arthroplasty posterior approach.
- •Patients willing to participate and sign informed consent
排除标准
- •Severe COPD/other contraindication to general anesthesia that spinal would be more suitable.
- •Patient with a weight of less than 41 kg
- •Dementia, not alert or Oriented to person, place, or time
- •Chronic pain patient with daily opioid use at home.
- •Patient with allergy to local anesthetics
- •Patient refusal
- •Total hip arthroplasty revision
- •Concomitant pain in different area from operative site.
- •Pregnancy
- •Patient with active infection on the injection sites for the blocks
- •Patients unable or willing to understand or comply with the study protocol
研究组 & 干预措施
CMP
Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml
干预措施: CMP (Drug)
Fascia iliaca
Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml
干预措施: Fascia Illica (Drug)
结局指标
主要结局
Measurement of opioid use
时间窗: 24 hours
Measurement of opioid use (mg) for pain control after surgery once patient in recovery area
次要结局
- Measurement of the pain control(24 hours)
研究者
Scott Byram MD
MD, Associate Professor
Loyola University